Cargando…

Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC)

Neo-chemoradiotherapy (nCRT) before surgery is a standard treatment for locally advanced esophageal cancers. However, the treatment outcome of nCRT varied with different patients. This study aimed to identify potential biomarkers for prediction of nCRT-response in patients with esophageal squamous c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jian, Yu, Pengyi, Luo, Judong, Sun, Zhiqiang, Yu, Jingping, Wang, Jianlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082678/ https://www.ncbi.nlm.nih.gov/pubmed/33935718 http://dx.doi.org/10.3389/fphar.2021.626972

Ejemplares similares

Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling
por: Wang, Jianlin, et al.
Publicado: (2020)

RAI14 silencing suppresses progression of esophageal cancer via the STAT3 pathway
por: Wang, Jianlin, et al.
Publicado: (2020)

Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy
por: De Mattia, Elena, et al.
Publicado: (2020)

The Safety and Efficacy of Apatinib Treatment in Addition to Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Esophageal Squamous Cell Carcinoma
por: Hu, Lijun, et al.
Publicado: (2020)

MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6
por: Wei, Lei, et al.
Publicado: (2020)

Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)
por: Lu, Yi-fang, et al.
Publicado: (2018)

Correction to: Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)
por: Lu, Yi-fang, et al.
Publicado: (2020)

Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)
por: Pu, Weilin, et al.
Publicado: (2017)

Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)
por: Wang, Yang, et al.
Publicado: (2013)

Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells
por: Chen, Chuangui, et al.
Publicado: (2017)

ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma
por: Tungekar, Asna, et al.
Publicado: (2018)

NRIP3 upregulation confers resistance to chemoradiotherapy in ESCC via RTF2 removal by accelerating ubiquitination and degradation of RTF2
por: Suo, Daqin, et al.
Publicado: (2020)

Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
por: Kong, Min, et al.
Publicado: (2020)

Evaluation of Roles of MicroRNA-21 and MicroRNA-18a in Esophageal Squamous Cell Carcinoma and Comparison of Their Changes in Expression Post-Chemoradiotherapy
por: Noor, Mohd Talha, et al.
Publicado: (2020)

Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients
por: Zhang, Cui-Ying, et al.
Publicado: (2019)

Polymorphisms in the ERCC5 Gene and Risk of Esophageal Squamous Cell Carcinoma (ESCC) in Eastern Chinese Populations
por: Zhu, Mei-Ling, et al.
Publicado: (2012)

Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model
por: Essack, Magbubah, et al.
Publicado: (2012)

Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
por: Yang, Pei-Wen, et al.
Publicado: (2019)

The role of microRNAs in depression
por: Ding, Ruidong, et al.
Publicado: (2023)

Correction: Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)
Publicado: (2014)

The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC)
por: Li, Zhuang-hua, et al.
Publicado: (2016)

The Aflibercept-Induced MicroRNA Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients Detected by Next-Generation Sequencing
por: Guo, Ju, et al.
Publicado: (2021)

Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK
por: Wang, Jia-Lin, et al.
Publicado: (2023)

Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in laryngeal squamous cell cancer
por: Huang, Yan, et al.
Publicado: (2021)

Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2022)

Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A)
por: Wang, Lan, et al.
Publicado: (2021)

The prognostic role of nutrition risk score (NRS) in patients with metastatic or recurrent esophageal squamous cell carcinoma (ESCC)
por: Zhou, Xia, et al.
Publicado: (2017)

CCGD-ESCC: A Comprehensive Database for Genetic Variants Associated with Esophageal Squamous Cell Carcinoma in Chinese Population
por: Peng, Linna, et al.
Publicado: (2018)

Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis
por: Yang, Howard, et al.
Publicado: (2020)

Comparative Clinical Efficacy of ‘Concurrent Chemoradiotherapy (CCRT) and Anlotinib’ Than CCRT in Patients with Locally Advanced ESCC
por: Wang, Gang, et al.
Publicado: (2022)

HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of Esophageal Squamous Cell Carcinoma (ESCC)
por: Yang, Ju, et al.
Publicado: (2014)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2021)

ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma
por: Ma, Xiao-Li, et al.
Publicado: (2019)

Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma
por: Liu, Changmin, et al.
Publicado: (2020)

Nicotine Activates YAP1 through nAChRs Mediated Signaling in Esophageal Squamous Cell Cancer (ESCC)
por: Zhao, Yue, et al.
Publicado: (2014)

Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model
por: Osei-Sarfo, Kwame, et al.
Publicado: (2015)

Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation
por: Li, Li-Yan, et al.
Publicado: (2015)

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)
por: Song, Qi, et al.
Publicado: (2021)

Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB)
por: Zhu, Yanping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jm6clg56dgpambhbi6tl4a24ef